Skip to main content
Caplight Logo









Sampling Human, Inc.

Sampling Human, Inc.

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://samplinghuman.com/

Last Round

VC Round

Aug 25, 2025

Total Funding Raised

$2.76M

Company Overview

Sampling Human, Inc. is a techbio company that develops single-cell analysis platforms and diagnostic kits for pre-symptomatic screening, personalized medicine, and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Drug Discovery

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

single-cell analysisbiocytometrydiagnostic reagent kitstechbiocell diagnosticssynthetic biologydrug discoveryflow cytometry alternativespatial omicsmachine learning analyticsearly disease detectionlab automationbioinformatics platformdigital biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sampling Human, Inc. Comparables

Compare Sampling Human, Inc. with similar companies based on industry and business-model similarity.

Sampling Human, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Partillion Bioscience Corporation
80%
10X Genomics
74%
Parse Biosciences
68%

Sampling Human, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 25, 2025
SeedApr 13, 2022
GrantMar 30, 2021
SeedApr 17, 2018

Key People

Founding team and executive leadership

Daniel Georgiev

Co-Founder And CEO

Founding Team

Sampling Human, Inc. Investors

Notable investors and investment history

Sampling Human, Inc. investors
InvestorRounds
bpd partnersSeed, VC Round
FundomoVC Round
Valhalla VenturesVC Round
Longevitytech.fundSeed
i&i PragueVC Round, Seed
Formic VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 26, 2025

    Acquired XENO Cell Innovations, a Czech subsidiary with a product engineering facility.

Sampling Human, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sampling Human, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sampling Human, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range24
Year Founded2021
Last FundingAug 25, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?